Seroquel in Bipolar Depression Versus SSRI
Public ClinicalTrials.gov record NCT00119652. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicentre, Double-blind, Randomised, Parallel Group, Placebo Controlled, Phase 3 Study of the Efficacy & Safety of Quetiapine Fumarate & Paroxetine as Monotherapy in Adult Patients With Bipolar Depression for 8 Weeks & Quetiapine in Continuation (Abbreviated)
Study identification
- NCT ID
- NCT00119652
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 676 participants
Conditions and interventions
Conditions
Interventions
- quetiapine fumarate (Seroquel) Drug
- paroxetine Drug
- mood stabilizing activity Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2005
- Primary completion
- Not listed
- Completion
- Apr 30, 2007
- Last update posted
- Jan 3, 2013
2005 – 2007
United States locations
- U.S. sites
- 28
- U.S. states
- 18
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | — | — |
| Research Site | Little Rock | Arkansas | — | — |
| Research Site | National City | California | — | — |
| Research Site | San Clemente | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | Maitland | Florida | — | — |
| Research Site | Winter Park | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Smyrna | Georgia | — | — |
| Research Site | Northfield | Illinois | — | — |
| Research Site | Oak Brook | Illinois | — | — |
| Research Site | New Orleans | Louisiana | — | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | Glen Burnie | Maryland | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Clementon | New Jersey | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Raleigh | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Dayton | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Irving | Texas | — | — |
| Research Site | Richmond | Virginia | — | — |
| Research Site | Bellevue | Washington | — | — |
| Research Site | Kirkland | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00119652, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 3, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00119652 live on ClinicalTrials.gov.